TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 2.250% 3/0
Principal, excl. options Q2 2024
254M
Holdings value Q2 2024
$204M
Value change Q2 2024
-$12.1M
Grand Portfolio weight change Q2 2024
0%
Number of holders
18
Number of buys Q2 2024
14
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $16.2K $1.41M +$1.41M $87.11 1
2024 Q2 $254M $204M -$12.1M $0.65 18
2024 Q1 $273M $213M -$34.1B $0.63 18
2023 Q4 $335M $220M +$27.1M $0.66 20
2023 Q3 $294M $216M +$1.58M $0.65 22
2023 Q2 $302M $245M -$10.6M $0.81 21
2023 Q1 $313M $325M +$10M $0.98 21
2022 Q4 $301M $275M -$26.9M $0.91 21
2022 Q3 $282M $289M -$826K $1.02 23
2022 Q2 $239M $244M -$22.6M $1.00 21
2022 Q1 $257M $280M +$280M $1.06 23